Related references
Note: Only part of the references are listed.Conformational changes in glutaminyl-tRNA synthetases upon binding of the substrates and analogs using molecular docking and molecular dynamics approaches
Mutharasappan Nachiappan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
In silico screening of anti-inflammatory compounds from Lichen by targeting cyclooxygenase-2
Tanuja Joshi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches
Srabanti Jana et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays
Sinosh Skariyachan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer
Lian Lian et al.
BMC CANCER (2019)
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
Shuang Qin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus
Muhammad Tahir Ul Qamar et al.
SCIENTIFIC REPORTS (2019)
Potential phytochemicals in the fight against skin cancer: Current landscape and future perspectives
Javed Iqbal et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7
Chhedi Lal Gupta et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Molecular Interaction and Computational Analytical Studies of Pinocembrin for its Antiangiogenic Potential Targeting VEGFR-2: A Persuader of Metastasis
Neha Sharma et al.
MEDICINAL CHEMISTRY (2018)
Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells
Harry Lee et al.
SCIENTIFIC REPORTS (2018)
Synthesis of Novel Pyrido[4,3-e][1,2,4]triazino[3,2-c][1,2,4] thiadiazine 6,6-dioxide Derivatives with Potential Anticancer Activity
Jaroslaw Slawinski et al.
MOLECULES (2016)
A simple model predicts UGT-mediated metabolism
Na Le Dang et al.
BIOINFORMATICS (2016)
Antiangiogenic cancer treatment: The great discovery and greater complexity (Review)
Ewa Maj et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Site of Reactivity Models Predict Molecular Reactivity of Diverse Chemicals with Glutathione
Tyler B. Hughes et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network
Tyler B. Hughes et al.
ACS CENTRAL SCIENCE (2015)
In silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases
Sathish Kumar Paramashivam et al.
BIOINFORMATION (2015)
YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models
Yong Xia et al.
SCIENTIFIC REPORTS (2014)
The Generation, Detection, and Effects of Reactive Drug Metabolites
Andrew V. Stachulski et al.
MEDICINAL RESEARCH REVIEWS (2013)
Identification, Design and Bio-Evaluation of Novel Hsp90 Inhibitors by Ligand-Based Virtual Screening
JianMin Jia et al.
PLOS ONE (2013)
Reactions and enzymes in the metabolism of drugs and other xenobiotics
Bernard Testa et al.
DRUG DISCOVERY TODAY (2012)
Antiangiogenic Therapy for Cancer: An Update
Belal Al-Husein et al.
PHARMACOTHERAPY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Immune pathomechanism of drug hypersensitivity reactions
Werner J. Pichler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Deleterious effects of reactive metabolites
Sabry M. Attia
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Mechanisms of Immune-Mediated Liver Injury
David H. Adams et al.
TOXICOLOGICAL SCIENCES (2010)
HSP90 manages the ends
Diane C. DeZwaan et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors
Yujia Dai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: Design, synthesis, and evaluations
Jean-Christophe Harmange et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Verification of the structural alerts for Michael acceptors
T. Wayne Schultz et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor
Yujia Dai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
1,4-Dihydroindeno[1,2-c]pyrazoles as novel multitargeted receptor tyrosine kinase inhibitors
Jurgen Dinges et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Clinical importance of the cytochromes P450
DW Nebert et al.
LANCET (2002)
Share Paper
